Literature DB >> 17294231

The biology and therapeutic potential of interleukin 27.

Marcel Batten1, Nico Ghilardi.   

Abstract

Interleukin (IL-) 27 is a helical cytokine of the greater IL-6/IL-12 family with a broad range of pro- and anti-inflammatory properties. It can skew T helper cell development, suppress T cell proliferation, stimulate cytotoxic T cell activity, induce isotype switching in B cells, and has diverse effects on innate immune cells. In vivo, its most important role appears to be that of immune regulation, as mice with defects in IL-27 or its receptor display enhanced immune responses in a range of infectious and noninfectious situations. In this review, we discuss the body of knowledge on IL-27 and its potential therapeutic utility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17294231     DOI: 10.1007/s00109-007-0164-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   5.606


  85 in total

1.  Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection.

Authors:  Michelle N Kelly; Jay K Kolls; Kyle Happel; Joseph D Schwartzman; Paul Schwarzenberger; Crescent Combe; Magali Moretto; Imtiaz A Khan
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity.

Authors:  David Artis; Alejandro Villarino; Michael Silverman; Weimian He; Elizabeth M Thornton; Sharon Mu; Shamin Summer; Todd M Covey; Elaine Huang; Hiroki Yoshida; Gary Koretzky; Michael Goldschmidt; Gary D Wu; Fred de Sauvage; Hugh R P Miller; Christiaan J M Saris; Phillip Scott; Christopher A Hunter
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

3.  Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1).

Authors:  Sakiko Shimizu; Naonobu Sugiyama; Kohsuke Masutani; Atsushi Sadanaga; Yoshiyuki Miyazaki; Yasushi Inoue; Mitsuteru Akahoshi; Ritsuko Katafuchi; Hideki Hirakata; Mine Harada; Shinjiro Hamano; Hitoshi Nakashima; Hiroki Yoshida
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

Review 4.  The T-box transcription factor T-bet in immunity and autoimmunity.

Authors:  Stanford L Peng
Journal:  Cell Mol Immunol       Date:  2006-04       Impact factor: 11.530

Review 5.  Pathological role of IL-6 in the experimental allergic bronchial asthma in mice.

Authors:  Aysefa Doganci; Kerstin Sauer; Roman Karwot; Susetta Finotto
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

6.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

7.  IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms.

Authors:  Sophie Lucas; Nico Ghilardi; Ji Li; Frédéric J de Sauvage
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

8.  Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection.

Authors:  David Artis; Leanne M Johnson; Karen Joyce; Christiaan Saris; Alejandro Villarino; Christopher A Hunter; Phillip Scott
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

9.  Control of effector CD8+ T cell function by the transcription factor Eomesodermin.

Authors:  Erika L Pearce; Alan C Mullen; Gislâine A Martins; Connie M Krawczyk; Anne S Hutchins; Valerie P Zediak; Monica Banica; Catherine B DiCioccio; Darrick A Gross; Chai-An Mao; Hao Shen; Nezih Cereb; Soo Y Yang; Tullia Lindsten; Janet Rossant; Christopher A Hunter; Steven L Reiner
Journal:  Science       Date:  2003-11-07       Impact factor: 47.728

10.  Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection.

Authors:  Shabaana A Khader; Santiago Partida-Sanchez; Guy Bell; Dawn M Jelley-Gibbs; Susan Swain; John E Pearl; Nico Ghilardi; Frederic J Desauvage; Frances E Lund; Andrea M Cooper
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  48 in total

1.  Effect of the N-butanoyl glutathione (GSH) derivative and acyclovir on HSV-1 replication and Th1 cytokine expression in human macrophages.

Authors:  Alessandra Fraternale; Giuditta Fiorella Schiavano; Maria Filomena Paoletti; Linda Palma; Mauro Magnani; Giorgio Brandi
Journal:  Med Microbiol Immunol       Date:  2014-03-29       Impact factor: 3.402

2.  The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses.

Authors:  Shaun A Summers; Richard K S Phoon; Joshua D Ooi; Stephen R Holdsworth; A Richard Kitching
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27.

Authors:  George D Kalliolias; Rachael A Gordon; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

4.  IL-27 structural analysis demonstrates similarities with ciliary neurotrophic factor (CNTF) and leads to the identification of antagonistic variants.

Authors:  Francois Rousseau; Laetitia Basset; Josy Froger; Nathalie Dinguirard; Sylvie Chevalier; Hugues Gascan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

Review 5.  Interleukin-12 and tuberculosis: an old story revisited.

Authors:  Andrea M Cooper; Alejandra Solache; Shabaana A Khader
Journal:  Curr Opin Immunol       Date:  2007-08-16       Impact factor: 7.486

Review 6.  Regulation and function of proinflammatory TH17 cells.

Authors:  Gustavo J Martinez; Roza I Nurieva; Xuexian O Yang; Chen Dong
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

7.  Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27.

Authors:  Yun Chen; Guoping Jiang; Horng-Ren Yang; Xiaodong Gu; Lianfu Wang; Ching-Chuan Hsieh; Hong-Shiue Chou; John J Fung; Shiguang Qian; Lina Lu
Journal:  J Hepatol       Date:  2009-06-13       Impact factor: 25.083

Review 8.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

9.  Interleukin-27 acts on hepatic stellate cells and induces signal transducer and activator of transcription 1-dependent responses.

Authors:  Caroline Schoenherr; Ralf Weiskirchen; Serge Haan
Journal:  Cell Commun Signal       Date:  2010-08-19       Impact factor: 5.712

10.  Failure of interferon gamma to induce the anti-inflammatory interleukin 18 binding protein in familial hemophagocytosis.

Authors:  Claudia A Nold-Petry; Thomas Lehrnbecher; Andrea Jarisch; Dirk Schwabe; Josef M Pfeilschifter; Heiko Muhl; Marcel F Nold
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.